1. Home
  2. NLSP vs ONFO Comparison

NLSP vs ONFO Comparison

Compare NLSP & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • ONFO
  • Stock Information
  • Founded
  • NLSP 2015
  • ONFO 2018
  • Country
  • NLSP Switzerland
  • ONFO United States
  • Employees
  • NLSP N/A
  • ONFO N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • ONFO Computer Software: Programming Data Processing
  • Sector
  • NLSP Health Care
  • ONFO Technology
  • Exchange
  • NLSP Nasdaq
  • ONFO Nasdaq
  • Market Cap
  • NLSP 5.9M
  • ONFO 5.8M
  • IPO Year
  • NLSP 2021
  • ONFO 2022
  • Fundamental
  • Price
  • NLSP $1.50
  • ONFO $1.09
  • Analyst Decision
  • NLSP
  • ONFO
  • Analyst Count
  • NLSP 0
  • ONFO 0
  • Target Price
  • NLSP N/A
  • ONFO N/A
  • AVG Volume (30 Days)
  • NLSP 102.5K
  • ONFO 57.5K
  • Earning Date
  • NLSP 05-14-2025
  • ONFO 04-16-2025
  • Dividend Yield
  • NLSP N/A
  • ONFO N/A
  • EPS Growth
  • NLSP N/A
  • ONFO N/A
  • EPS
  • NLSP N/A
  • ONFO N/A
  • Revenue
  • NLSP N/A
  • ONFO $7,862,077.00
  • Revenue This Year
  • NLSP N/A
  • ONFO N/A
  • Revenue Next Year
  • NLSP N/A
  • ONFO N/A
  • P/E Ratio
  • NLSP N/A
  • ONFO N/A
  • Revenue Growth
  • NLSP N/A
  • ONFO 50.04
  • 52 Week Low
  • NLSP $1.30
  • ONFO $0.49
  • 52 Week High
  • NLSP $18.40
  • ONFO $1.88
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 49.86
  • ONFO 51.08
  • Support Level
  • NLSP $1.38
  • ONFO $1.05
  • Resistance Level
  • NLSP $1.53
  • ONFO $1.14
  • Average True Range (ATR)
  • NLSP 0.09
  • ONFO 0.09
  • MACD
  • NLSP 0.02
  • ONFO 0.02
  • Stochastic Oscillator
  • NLSP 64.91
  • ONFO 70.00

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About ONFO Onfolio Holdings Inc.

Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.

Share on Social Networks: